Improving management of anemia before surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the management of preoperative anemia in patients attending a preanesthesia clinic. It aims to evaluate the adherence to newly implemented guidelines designed to optimize red blood cell mass before elective surgeries. The study will assess the prevalence and causes of anemia among surgical patients, particularly focusing on those with chronic kidney disease and other underlying conditions. By identifying and managing anemia effectively, the study seeks to improve surgical outcomes and reduce complications associated with blood loss during surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria Patients who attend a preanesthesia clinic and have anemia.

Anemia defined as

1. Patients, with chronic kidney disease (CKD) stage 3+ or hematologic disease, have a hemoglobin level less than 10 g/dL; or
2. Patients other than No. 1 and have hemoglobin level less than 13 g/dL in men or a hemoglobin level less than 12 g/dL in women.

Exclusion Criteria:

* none

Where it's running

• Siriraj hospital
  Bangkok, Bangkok, Thailand Recruiting

Study contacts

• Principal investigator: Mingkwan Wongyingsinn — Siriraj Hospital
• Study coordinator: Mingkwan Wongyingsinn, MD
• Email: mingkwan.won@mahidol.ac.th
• Phone: 024197995

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DISC-0974-201 for adults with IBD-related anemia

  This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.

  Recruiting at 15 sites Phase 2 Disc Medicine, Inc · Birmingham, Alabama and 14 other locations · NCT07368972

• National registry for people with myelofibrosis and anemia in Germany.

  This project will collect health, treatment, and quality-of-life information from people in Germany with primary or secondary myelofibrosis and anemia to see how their care and symptoms change over time.

  Recruiting iOMEDICO AG · Multiple Locations · NCT06976918

• Evaluating DISC-0974 for treating anemia in myelofibrosis patients

  This study tests if a new treatment called DISC-0974 can help people with myelofibrosis who have anemia feel better and improve their condition.

  Recruiting at 33 sites Phase 1/2 Disc Medicine, Inc · Gilbert, Arizona and 34 other locations · NCT05320198

• Iron status at ICU discharge in adults with anemia after critical illness

  We are testing whether iron deficiency is common at ICU discharge and whether it relates to how well patients recover after leaving the ICU.

  Recruiting Università degli Studi di Ferrara · Brussels and 3 other locations · NCT07781540

• Luspatercept for anemia due to chronic kidney disease

  This study tests whether luspatercept can raise hemoglobin levels in people with anemia caused by CKD and whether it is safe.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07725497

• Guideline Adherence in HFrEF: See If Mirror Information Helps Doctors and Patients Follow GDMT

  This study tests whether showing doctors, or both doctors and patients, mirror information about how well guideline-directed medical therapy is being used in heart failure with reduced ejection fraction.

  Recruiting Erasmus Medical Center · Rotterdam · NCT07702760

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.